Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy

Sung Hoon Kim, Sae-Byeol Choi, Jae Gil Lee, Seung Up Kim, Mi Suk Park, Do Young Kim, Jin Sub Choi, Kyung Sik Kim

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection. Patients and Methods: Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed. Results: Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6%, and the actual disease-free survival (DFS) rate was 24. 1%. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS. Conclusions: The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5-10-cm HCC.

Original languageEnglish
Pages (from-to)598-607
Number of pages10
JournalJournal of Gastrointestinal Surgery
Volume15
Issue number4
DOIs
Publication statusPublished - 2011 Apr 1

Fingerprint

Hepatitis B e Antigens
Hepatectomy
Hepatocellular Carcinoma
Disease-Free Survival
Survival Rate
Survival
Hepatitis B
Medical Records
Multivariate Analysis
Recurrence
Liver

Keywords

  • 10-Year survival
  • HBeAg
  • Hepatocellular carcinoma
  • Tumor size

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy. / Kim, Sung Hoon; Choi, Sae-Byeol; Lee, Jae Gil; Kim, Seung Up; Park, Mi Suk; Kim, Do Young; Choi, Jin Sub; Kim, Kyung Sik.

In: Journal of Gastrointestinal Surgery, Vol. 15, No. 4, 01.04.2011, p. 598-607.

Research output: Contribution to journalArticle

Kim, Sung Hoon ; Choi, Sae-Byeol ; Lee, Jae Gil ; Kim, Seung Up ; Park, Mi Suk ; Kim, Do Young ; Choi, Jin Sub ; Kim, Kyung Sik. / Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy. In: Journal of Gastrointestinal Surgery. 2011 ; Vol. 15, No. 4. pp. 598-607.
@article{0be731c7e15f442b9c7410dd277b9234,
title = "Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy",
abstract = "Purpose: There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection. Patients and Methods: Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed. Results: Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6{\%}, and the actual disease-free survival (DFS) rate was 24. 1{\%}. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS. Conclusions: The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5-10-cm HCC.",
keywords = "10-Year survival, HBeAg, Hepatocellular carcinoma, Tumor size",
author = "Kim, {Sung Hoon} and Sae-Byeol Choi and Lee, {Jae Gil} and Kim, {Seung Up} and Park, {Mi Suk} and Kim, {Do Young} and Choi, {Jin Sub} and Kim, {Kyung Sik}",
year = "2011",
month = "4",
day = "1",
doi = "10.1007/s11605-011-1452-7",
language = "English",
volume = "15",
pages = "598--607",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy

AU - Kim, Sung Hoon

AU - Choi, Sae-Byeol

AU - Lee, Jae Gil

AU - Kim, Seung Up

AU - Park, Mi Suk

AU - Kim, Do Young

AU - Choi, Jin Sub

AU - Kim, Kyung Sik

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Purpose: There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection. Patients and Methods: Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed. Results: Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6%, and the actual disease-free survival (DFS) rate was 24. 1%. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS. Conclusions: The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5-10-cm HCC.

AB - Purpose: There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection. Patients and Methods: Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed. Results: Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6%, and the actual disease-free survival (DFS) rate was 24. 1%. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS. Conclusions: The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5-10-cm HCC.

KW - 10-Year survival

KW - HBeAg

KW - Hepatocellular carcinoma

KW - Tumor size

UR - http://www.scopus.com/inward/record.url?scp=79953120380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953120380&partnerID=8YFLogxK

U2 - 10.1007/s11605-011-1452-7

DO - 10.1007/s11605-011-1452-7

M3 - Article

C2 - 21336497

AN - SCOPUS:79953120380

VL - 15

SP - 598

EP - 607

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 4

ER -